We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Stahl Online is a one-stop shop, covering everything a mental health professional or teacher will ever need to know about neuropsychopharmacology. Comprehensive and regularly updated, Stahl Online provides full access to the entire current portfolio of books by Dr Stephen M. Stahl.
Stahl Online is a one-stop shop, covering everything a mental health professional or teacher will ever need to know about neuropsychopharmacology. Comprehensive and regularly updated, Stahl Online provides full access to the entire current portfolio of books by Dr Stephen M. Stahl.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
For decades, psychiatry has focused on initiating treatment—which medication to prescribe, in what dose, and for how long. But what happens when treatment needs to stop? How a medication is stopped is just as important as how it is started, and abrupt discontinuation can lead to unnecessary suffering, relapse, and often preventable withdrawal symptoms. Based on the principles of the bestselling Stahl's Prescriber's Guide, this essential resource provides user-friendly guidance on deprescribing or switching psychotropic medications safely and effectively. 64 medications are presented in a consistent format to facilitate rapid access to deprescribing information. Divided into color coded sections, the book allows the reader to identify key details about when and why to deprescribe, the risks and mechanisms of withdrawal, tapering protocols, cross-titration strategies, and how to distinguish withdrawal symptoms from relapse. Evidence-based recommendations and expert clinical insights make this a must-have manual for all psychiatric prescribers.
This extensively revised second edition provides a user-friendly step-by-step manual on the range of psychotropic medications prescribed for children and adolescents by clinicians and nurse practitioners. Boasting nearly double the medications of the first edition, it features new sections related to pharmacokinetics and pharmacogenetics in children and adolescents alongside algorithms for addressing frequently encountered disorders such as anxiety, depression, bipolar disorder, ADHD, and OCD. Based on the best-seller, Stahl's Prescriber's Guide, and using a full-color template-driven navigation system, it combines evidence-based data with clinically informed guidance to support prescribers in the field. Each drug is presented in the same classic design format with illustrated guidance on dosing, titration, and pharmacogenetics/metabolism. Color-coded sections distinguish clearly the information presented on therapeutics, safety and tolerability, dosing and use, what to expect, and the art of psychopharmacology, and are followed by updated and new key references. A must-have guide for all mental health professionals.
With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present the Eighth Edition of the world's best-selling formulary in psychopharmacology. The new edition features seven brand new compounds as well as information about several newly approved formulations of existing drugs. Many important new indications are covered for existing drugs, as are updates to the profiles of the entire content and collection, including new injectable and transdermal formulations, as well as updated warnings and indications. The icons and Pearls have been refreshed throughout, and with the book's its easy-to-use, full-colour template-driven navigation system, Prescriber's Guide combines evidence-based data with clinically informed advice to support everyone who is prescribing in the field of mental health.
This new volume in Stahl's Case Studies series presents the continuation of Dr. Schwartz's previous successful collection of psychopharmacology cases from Volume 2, this time in collaboration with Dr. Radonjić and editing from Dr. Stahl. Here they illustrate common questions and dilemmas routinely encountered in psychopharmacologic day-to-day practice. Following a consistent user-friendly layout, each case features icons, tips, and questions about diagnosis and management as it progresses over time, a pre-case self-assessment question, followed by the correct answers at the end. Formatted in alignment with the American Board of Psychiatry and Neurology's maintenance of psychiatry specialty certification, cases address issues in a relevant and understandable way. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging the complications, issues, decisions, twists, and turns along the way. This is psychiatry in real life.
The new edition of 'Stahl's Illustrated Pharmacological Treatments for Psychosis' (previously entitled 'Stahl's Illustrated Antipsychotics') provides the essential practical support required by anyone treating people with psychosis in the field of mental health. Incorporating information on the newest indications, formulations, recommendations, and safety data, all presented in a clear concise manner alongside informative and easy-to-understand illustrations. 'Stahl's Illustrated Pharmacological Treatments for Psychosis 3e' is a concise guide, with all concepts illustrated by full-color figures and tables, that will be familiar to readers of 'Stahl's Essential Psychopharmacology' and the 'Prescriber's Guide'. The visual learner will find that this book makes psychopharmacological concepts easier to master, and the non-visual learner will enjoy this book's short explanations of complex psychopharmacological concepts. Each chapter builds upon previous ones, synthesizing information about basic biology, diagnostics, treatment plans, complications, and comorbidities. This book is the essential guide for mental health providers caring for psychiatric patients.
Mental health professionals routinely make treatment decisions without necessarily having an overarching perspective about optimal next steps. This important new book provides them with reader-friendly, pragmatic strategies to approach clinical problems as testable hypotheses. It discusses how to apply concepts based on decision analytic theory using risk-benefit analyses, contingency planning, measurement-based care, shared decision making, pharmacogenetics, disease staging, and machine learning. Readers will learn how these tools can help them craft optimal pharmacological and psychosocial interventions tailored to the needs of an individual patient. The book covers topics such as diagnostic ambiguity, interview technique, applying statistical concepts to individual patients, artificial intelligence, and managing high-risk, treatment-resistant, or demanding and difficult patients. Valuable clinical vignettes are featured throughout the book to illustrate common dilemmas and scenarios where the relative merits of competing treatment options invite a more iterative than definitive approach. For all healthcare professionals who prescribe psychotropic medications.
This brand-new fourth volume in Stahl's Case Studies series presents a selection of clinical case studies in child and adolescent psychopharmacology, taken from Dr. Strawn's clinics and consultations. These cases illustrate common questions that are routinely asked by Dr. Strawn's peers in consultations and which represent dilemmas in the day-to-day practice of pediatric psychopharmacology. Followings a consistent, user-friendly layout, each case features icons, tips and questions about diagnosis and management as it progresses over time, a pre-case self-assessment question, followed by the correct answers at the end of the case. Formatted in alignment with the American Board of Psychiatry and Neurology's maintenance of psychiatry speciality certification, cases address multifaceted issues in a relevant and understandable way. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way.
Worldwide efforts to promote greater lithium use for mood disorders have increased the need for evidence-based guidance addressing key questions related to initiation, monitoring and adverse effect management. This practical handbook provides clinicians with a detailed explanation of lithium's renal journey, how this informs our understanding of polyuria pathogenesis and how medications or hyponatremia can alter lithium clearance. Covering efficacy, pharmacokinetics, toxicity, discontinuation, and use in special patient groups including pregnant and breastfeeding women, older or younger patients, each section also provides a detailed background for its suggested logical approach to managing lithium's renal and other adverse effects. Using the latest data, the book outlines rationales for specific management decisions, and prioritizes options to provide clinical guidance on the best course of action. Colour-coded lists and tables, bulleted text, and diagrams illustrate important points throughout, helping to make information accessible and easy-to-digest. An essential resource for mental health professionals worldwide.
Fully updated, this new edition continues to present information in a clear, illustrative, and concise manner. Replacing both Stahl's Illustrated Antidepressants and Stahl's Illustrated Mood Stabilizers, this concise and illustrated guide examines the full spectrum of symptoms included in mood disorders from mania to depression to mixed states in between, the neurocircuitry underlying these symptoms, and the evidence-based therapeutic targets for treatment. Concepts are illustrated by full-color figures, images, and tables making psychopharmacology concepts within this book easy to master for the visual learner. Non-visual learners can enjoy a shortened text version of complex psychopharmacology concepts. Each chapter builds on previous chapters, synthesizing information from basic biology and diagnostics to building treatment plans and dealing with complications and comorbidities. The interaction between the images and text allows the reader to vividly conceptualize complex pharmacologies and a Suggested Reading section guides readers toward more in-depth learning about particular concepts.
As an excellent source of learning for prescribers specializing in psychiatry, primary care physicians, nurse practitioners, psychologists, and pharmacists, this new edition features approximately 150 questions, divided into ten core areas of psychiatry, helping to identify areas in which you need further study. The majority of questions are new or updated in their explanations and referencing. Each question is followed by an explanation of the answer and a list of references. After completing the questions you will be better able to: diagnose patients presenting with psychiatric symptoms using accepted diagnostic standards and practices; implement evidence-based psychiatric treatment strategies aligned with the patient's recovery goals; integrate recent advances in diagnostic and treatment strategies into clinical practice according to best practice guidelines. This collection has been approved by the American Board of Psychiatry and Neurology as part of a lifelong learning and self-assessment program and as a component of maintenance of certification.
The eagerly anticipated fifth edition of Dr Stahl's essential textbook of psychopharmacology is here! Using Dr Stahl's unique 'visual language', the book is the single most readable source of information on disease and drug mechanisms for all students and mental health professionals seeking to understand and utilize current therapeutics, and to anticipate the future for novel medications. The new edition includes over 500 new or refreshed figures, an intuitive color scheme, 14 new uses for older drugs and 18 brand new drugs, coverage of Parkinson's Disease Psychosis, behavioural symptoms of dementia, and mixed features in major depressive episodes, and expanded information on the medical uses of cannabis and hallucinogen assisted psychotherapy. This product combines the fifth edition of the textbook with a one-year subscription to www.stahlonline.org, providing access to the full range of Dr Stahl's content. The one-year subscription is activated via a code provided with the printed book.
All of the titles in the Stahl's Illustrated series are designed to be fun. Concepts are illustrated by full-color images that will be familiar to all readers of Stahl's Essential Psychopharmacology, 3rd Edition and The Prescriber's Guide. The visual learner will find that these books make psychopharmacology concepts easy to master, while the non-visual learner will enjoy a shortened text version of complex psychopharmacology concepts. Within each book, each chapter builds on previous chapters, synthesizing information from basic biology and diagnostics to building treatment plans and dealing with complications and comorbidities. Novices may want to approach Stahl's Illustrated series by first looking through all the graphics and gaining a feel for the visual vocabulary. Readers more familiar with these topics should find that going back and forth between images and text provides an interaction with which to vividly conceptualize complex pharmacologies. And, to help guide the reader toward more in-depth learning about particular concepts, each book ends with a Suggested Reading section.
Long established as the preeminent source in its field, the eagerly anticipated fifth edition of Dr Stahl's essential textbook of psychopharmacology is here! With its use of icons and figures that form Dr Stahl's unique 'visual language', the book is the single most readable source of information on disease and drug mechanisms for all students and mental health professionals seeking to understand and utilize current therapeutics, and to anticipate the future for novel medications. Every aspect of the book has been updated, with the clarity of explanation that only Dr Stahl can bring. The new edition includes over 500 new or refreshed figures, an intuitive color scheme, fourteen new uses for older drugs and eighteen brand new drugs, coverage of Parkinson's Disease Psychosis, behavioural symptoms of dementia, and mixed features in major depressive episodes, and expanded information on the medical uses of cannabis and hallucinogen assisted psychotherapy.
This full-color, practical handbook provides a concise, evidence-based psychopharmacological approach to the management of complex treatment-resistant psychotic disorders. Part I focuses uniquely on topics and strategies relevant to treating this challenging patient population. These approaches go beyond standard guidelines while adhering to research and clinically derived data. Part II provides a concise array of information regarding those classes of medications most commonly used when treating complex treatment-resistant psychotic disorders. Each medication guide contains sections including mechanisms of action, typical treatment response, monitoring, dosing and kinetics, medications to avoid in combination/warnings, and take-home pearls. Part III offers tips in brief appendix chapters for managing common issues ranging from loading lithium and valproic acid to the treatment of acute psychomotor agitation. An essential resource for psychiatrists, forensic clinicians, psychiatric trainees, and all mental health professionals involved with, or interested in, the treatment of challenging psychotic disorders.
Despite the lack of guidance available for practitioners, extensive polypharmacy has become the primary method of treating patients with severe and chronic mood, anxiety, psychotic or behavioral disorders. This ground-breaking new book provides an overview of psychopharmacology knowledge and decision-making strategies, integrating findings from evidence-based trials with real-world clinical presentations. It adopts the approach and mind-set of a clinical investigator and reveals how prescribers can practice 'bespoke psychopharmacology', tailoring care to the individualized needs of patients. Practitioners at all levels of expertise will enhance their ability to devise rationale-based treatments, targeting manifestations of dysfunctional neural circuitry and dimensions of psychopathology that cut across conventional psychiatric diagnoses. Presented in a user-friendly, practical, full-colour layout and incorporating summary tables, bullet points, and illustrative case vignettes, it is an invaluable guide for all healthcare professionals prescribing psychotropic medications, including psychiatry specialists, primary care physicians, and advanced practice registered nurses.
With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present the Seventh Edition of the world's best-selling formulary in psychopharmacology. The new edition features nine new compounds as well as information about several new formulations of existing drugs. Many important new indications are covered for existing drugs, as are updates to the profiles of the entire content and collection, including new injectable and transdermal formulations, as well as updated warnings and indications. The Pearls have all been refreshed and the antipsychotics section has been completely revised. With its easy-to-use, full-colour template-driven navigation system, Prescriber's Guide combines evidence-based data with clinically informed advice to support everyone who is prescribing in the field of mental health.
Reports reveal an increase in the number of individuals with serious mental illness in jails, prisons and forensic hospitals. Despite the wide-ranging and devastating consequences of this 'criminalization' of mental illness, there remains a lack of information on the subject as well as on the provision of care for these patients. This important new book fills a gap in the literature by examining topics such as: the history and policy factors related to criminalization; original research on forensic populations; pharmacological and psychological treatment strategies; and principles and guidelines for diversion out of the criminal justice system. Contributions from leading experts in the field further our understanding of this important subject, offering advice on how to provide humane care for patients. A must have for all mental health clinicians including psychiatrists, psychologists, social workers, rehabilitation therapists, and mental health nurses. A useful tool for mental health administrators and policy makers.
Child and adolescent psychopharmacology is a rapidly growing field with psychotropic medications used widely in the treatment of this patient group. However, psychopharmacological treatment guidelines used for adults cannot simply be applied for children or adolescents, thus presenting clinicians and nurse practitioners with assessment and prescribing challenges. Based on the best-selling resource Stahl's Prescriber's Guide, this new book provides a user-friendly step-by-step manual on the range of psychotropic drugs prescribed for children and adolescents by clinicians and nurse practitioners. Reviewed by expert child and adolescent psychiatrists, the medications are presented in the same design format in order to facilitate rapid access to information. Each drug is broken down into a number of sections, each designated by a unique color background thereby clearly distinguishing information presented on therapeutics, safety and tolerability, dosing and use, what to expect, special populations, and the art of psychopharmacology, and followed by key references.
The association between violence and mental illness is well studied, yet remains highly controversial. Currently, there does appear to be a trend of increasing violence in hospital settings, including both civilly and forensically committed populations. In fact, physical aggression is the primary reason for admission to many hospitals. Given that violence is now often both a reason for admission and a barrier to discharge, there is a pressing need for violence to be re-conceptualized as a primary medical condition, not as the by-product of one. Furthermore, treatment settings need to be enhanced to address the new types of violence exhibited in inpatient environments and this modification needs to be geared toward balancing safety with treatment. This book focuses on violence from assessment, through underlying neurobiology, to treatment and other recommendations for practice. This will be of interest to forensic psychiatrists, general adult psychiatrists, psychiatric residents, psychologists, psychiatric social workers and rehabilitation therapists.